Gurevičienė G. PD-L1 INHIBITOR ATEZOLIZUMAB▼ - FOR NSCLC TREATMENT AFTER PRIOR CHEMOTHERAPY. PIA [Internet]. 2020Sep.18 [cited 2024May19];3(1):102-8. Available from: http://pia.pulmoalerg.lt/index.php/PIA/article/view/154